FDA Extreme Trades: 16 Stocks Under $5

Started Jun 27 2009 at 3:06PM (EST) (By MikeHavRx)

Symbols: ANPI, NURO, HEB, DDSS, HGSI, VION, SNTS, BSDM, ISTA, TRIB, CTIC, APPA, BDSI

FDA Extreme Trades: 16 Stocks Under $5

TRIB, ANPI, NURO, BSDM, HEB, NEPH, SNTS, DDSS, NRIFF, CTIC, ISTA, VION, IGXT, APPA, THTCF, HGSI

Source: biomedreports.com

Below are FDA extreme trades among 16 companies with stock prices under $5 from the BioMedReports FDA Calendar which have pending FDA decisions for either new drug products, biological agents, medical devices, or diagnostic tests that may have a major impact on each of the underlying stock prices.

1 Comments

New

Optimusprime

Optimusprime

Jun 27 2009 at 6:47PM (EST)

Of the 16, NRIFF.PK is off my radar. Are they not in the grey market. NEPH has, for me, the greatest return potential. I have heard it could go as high as 7X. I shorted BDSI on Friday and turned a profit. I'm looking to get into NEPH on Monday. Hopefully, I'll jump back into BDSI before the middle of the month. ISTA is second after NEPH, but it has a date of 9/12/2009. HEB scares the hell out of me. It had a $0.45 change on Friday, but it has had wild mood swings every time Adam decides to slam the stock. I am steering clear from Adam's attack. DDSS is in third place for me. With a 7/18/2009, DDSS should jump to $2.50 next week. As the FDA starts approving or denying some of these drugs, people will start jumping from one stock to another. I think July will be a tremendous month for BioPharma's & BioTech's. July is a gold mine field for those that can navigate in and out at the right time. GLTA!

This post is more than 60 days old. Replying to it might be confusing for other members reading the discussion. By all means, keep the ball rolling and post a new opinion.

Ranked Top 1%

MikeHavRx

(Why follow?)

MikeHavRx

  • Returns
  • Today0.92%
  • Monthly Avg8.68%
  • (Vs. S&P 500)5.36%
  • YTD24.67%
  • Stats
  • Member SinceDec '08
  • Trades/Month21.1
  • Sectors Healthcare
  • Risk
  • Volatility (STD)High
  • S&P Correlation (R²)24.7%
  • Beta0.98
- Advertisement -